Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envafolimab + Endostatin in MSS Colorectal Cancer
NCT05551247Phase 2Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Sep 2022
- Primary completion
- Jun 2023
- Modality
- Nanobodies (VHH), Monoclonal Antibodies
01
Overview
A Phase 2 trial of envafolimab in colorectal cancer (CRC), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
envafolimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05551247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551247.